特纳综合征和肝腺瘤:一个病例报告
1Endocrinology, Diabetes and Metabolism, University of California, Los Angeles, USA.
Cureus
|December 8, 2025
概括
这份病例报告强调了一个患有特纳综合征 (TS) 和长期口服雌激素使用的女性的大型肝腺瘤. 需要进一步的研究,以澄清肝腺瘤在TS和查方案中的发病率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
背景情况:
- 特纳综合征 (TS) 与各种健康风险有关.
- 激素替代疗法,特别是口服雌激醇,在TS管理中很常见.
- 代谢综合征可以与TS共存,可能影响肝脏健康.
研究的目的:
- 在患有TS的女性中报告一个大型肝腺瘤病例.
- 讨论TS患者肝腺瘤的潜在风险增加.
- 确定有关肝腺瘤和TS的未来研究的关键领域.
主要方法:
- 案例报告的呈现方式.
- 对患者病史的审查,包括口服雌激醇暴露和代谢综合征.
- 关于肝腺瘤和特纳综合征的文献综述.
主要成果:
- 一名35岁的TS女性呈现出大型肝腺瘤.
- 该患者有长期口服雌激醇暴露和代谢综合征的病史.
- 这一案例表明TS,雌激醇和肝腺瘤之间存在潜在联系.
结论:
- 患有特纳综合征的患者可能有肝腺瘤的风险增加.
- 需要进一步调查以确定TS肝腺瘤的发病率.
- 未来的研究应该探索最佳查策略和不同雌激醇配方在肝腺瘤TS患者的安全性.
相关概念视频
Hyperthyroidism II: Pathophysiology
58
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
58
Cirrhosis I: Introduction
32
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
32
Hepatic Encephalopathy
71
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
71


